Wang Ying (center), general manager of Beijing Changping Technology Innodevelop Group, interacts with participants at the Silicon Valley Innovation & Entrepreneurship Forum on July 15, 2017. [Photo provided to China Daily] |
Beijing Changping helps companies to integrate AI into biomedical field; plans lab in the US
Beijing Changping Technology InnoDevelop Group or BCTID, an enterprise founded in 2015 by the Changping district government to specialize in applications of artificial intelligence in biomedicine, said it will build an online platform to help local high-tech enterprises expand globally.
According to Wang Mo, strategic cooperation director of the State-owned enterprise, BCTID will also help set up an international cooperative biomedical laboratory in California this year.
The lab will promote cooperation between Chinese and US enterprises for scientific research and resource integration with the aim of integrating AI into biomedicine.
Details of the planned California lab are still under wraps. Wang declined to identify BCTID's partner. "We value their skills and talents, and they appreciate our effectiveness, capabilities and business background," she said.
"Artificial intelligence will be widely used in the medical field. By the end of the year, about half of the leading healthcare systems will adopt some form of artificial intelligence in their diagnostics," said Mark Michalski, executive director of the Clinical Data Science Center of the BWH.
Based in Changping, a district northwest of capital Beijing, BCTID boasts several resources including investable funds, industry presence and links to human resources throughout China.
It combines its resources seamlessly across functions like investments, creation of physical space for the ventures it backs and related services.
BCTID links diverse innovation-related elements and industry resources so that their integration could help micro, small and medium enterprises to succeed.
It also invests in startups and helms resource-sharing platforms and initiatives relating to innovation in health and medical fields. It works with global incubators, venture capital firms and other partners to carry out cross-border innovation services.
BCTID sees itself as an enabler that promotes industry investment and cooperation. It follows instructions of the Zhongguancun Science Park of the Changping Park Management Committee.
It focuses on the development and operation of industrial park assets, and the integration of incubation and scientific technology service systems.
In addition, it carries out equity and integrated comprehensive financial services, in order to achieve the integration of space, service, finance, information, technology and talent, thus creating an ecosystem conducive to the development of technology enterprises.